Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Susheela Madhu"'
Autor:
Nishitha Reddy, Edwin P. Alyea, Sairah Ahmed, Susheela Madhu, Madan Jagasia, David B. Miklos, Tiffany Hill, Maria Guillermo-Pacheco, Olalekan O. Oluwole, Luciano J. Costa, Laura Dugger, Kelly Chyan, Ted Jackson Miller, Brittney Baer
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S403-S404
Background Ibrutinib is approved for a variety of B-cell malignancies, including CLL and MCL, and for chronic GVHD (cGVHD), failing ≥ 1 line of systemic therapy. Allogeneic HCT is curative for CLL and MCL, but success is limited due to relapse or G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e500ee23129a2b87c0fa3c3ee2a6f0d8
https://doi.org/10.1016/j.bbmt.2018.12.819
https://doi.org/10.1016/j.bbmt.2018.12.819
